Nano-X Imaging (NASDAQ:NNOX – Get Free Report) is expected to be announcing its Q1 2026 results before the market opens on Monday, July 20th. Analysts expect Nano-X Imaging to post earnings of ($0.20) per share and revenue of $4.5380 million for the quarter. Individuals can find conference call details on the company’s upcoming Q1 2026 earning summary page for the latest details on the call scheduled for Thursday, June 25, 2026 at 8:30 AM ET.
Nano-X Imaging (NASDAQ:NNOX – Get Free Report) last issued its quarterly earnings results on Thursday, June 25th. The company reported ($0.16) earnings per share (EPS) for the quarter. The company had revenue of $4.31 million during the quarter. Nano-X Imaging had a negative net margin of 716.44% and a negative return on equity of 70.96%. On average, analysts expect Nano-X Imaging to post $-1 EPS for the current fiscal year and $-0 EPS for the next fiscal year.
Nano-X Imaging Price Performance
Shares of NASDAQ:NNOX opened at $1.12 on Friday. The company has a market capitalization of $77.94 million, a P/E ratio of -0.71 and a beta of 1.24. The business’s 50 day simple moving average is $1.57 and its 200 day simple moving average is $2.18. Nano-X Imaging has a 1 year low of $0.73 and a 1 year high of $5.69.
Institutional Trading of Nano-X Imaging
Wall Street Analyst Weigh In
A number of research analysts recently commented on NNOX shares. Alliance Global Partners cut Nano-X Imaging from a “buy” rating to a “neutral” rating and decreased their price target for the stock from $5.00 to $3.00 in a research report on Tuesday, July 7th. Zacks Research upgraded Nano-X Imaging from a “strong sell” rating to a “hold” rating in a research note on Monday, June 22nd. D. Boral Capital reaffirmed a “buy” rating and issued a $5.00 target price on shares of Nano-X Imaging in a report on Monday, April 20th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Nano-X Imaging in a research note on Wednesday, July 8th. Two analysts have rated the stock with a Strong Buy rating, one has given a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Nano-X Imaging has an average rating of “Moderate Buy” and a consensus target price of $4.00.
Check Out Our Latest Report on Nano-X Imaging
About Nano-X Imaging
Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.
The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes.
Featured Articles
- Five stocks we like better than Nano-X Imaging
- Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop
- Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs?
- The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story
- Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Receive News & Ratings for Nano-X Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nano-X Imaging and related companies with MarketBeat.com's FREE daily email newsletter.
